XML 42 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Business Segments (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2025
Business Segments |
Schedule of information regarding reportable segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months |  | Nine Months
For the Periods Ended March 31 |  | 2025 |  | 2024 |  | 2025 |  | 2024
Net sales |  |  |  |  |  |  |  |  |  |  |  |
Animal Health | ​ | $ | 258,377 | ​ | $ | 181,333 | ​ | $ | 670,318 | ​ | $ | 514,967
Mineral Nutrition | ​ |  | 66,774 | ​ |  | 64,228 | ​ |  | 189,086 | ​ |  | 181,601
Performance Products | ​ |  | 22,674 | ​ |  | 17,662 | ​ |  | 58,114 | ​ |  | 47,947
Total segments | ​ | $ | 347,825 | ​ | $ | 263,223 | ​ | $ | 917,518 | ​ | $ | 744,515
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 11,369 | ​ | $ | 7,695 | ​ | $ | 29,318 | ​ | $ | 22,392
Mineral Nutrition | ​ |  | 524 | ​ |  | 601 | ​ |  | 1,555 | ​ |  | 1,907
Performance Products | ​ |  | 277 | ​ |  | 432 | ​ |  | 902 | ​ |  | 1,291
Total segments | ​ | $ | 12,170 | ​ | $ | 8,728 | ​ | $ | 31,775 | ​ | $ | 25,590
Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 63,123 | ​ | $ | 36,524 | ​ | $ | 161,684 | ​ | $ | 104,317
Mineral Nutrition | ​ |  | 5,762 | ​ |  | 4,665 | ​ |  | 15,226 | ​ |  | 11,053
Performance Products | ​ |  | 3,336 | ​ |  | 2,371 | ​ |  | 7,513 | ​ |  | 4,597
Total segments | ​ | $ | 72,221 | ​ | $ | 43,560 | ​ | $ | 184,423 | ​ | $ | 119,967
Reconciliation of income before income taxes to Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income before income taxes | ​ | $ | 29,688 | ​ | $ | 12,922 | ​ | $ | 44,146 | ​ | $ | 4,508
Interest expense, net | ​ |  | 9,355 | ​ |  | 4,575 | ​ |  | 25,992 | ​ |  | 13,798
Depreciation and amortization – Total segments | ​ |  | 12,170 | ​ |  | 8,728 | ​ |  | 31,775 | ​ |  | 25,590
Depreciation and amortization – Corporate | ​ |  | 446 | ​ |  | 468 | ​ |  | 1,419 | ​ |  | 1,387
Corporate costs | ​ | ​ | 17,335 | ​ | ​ | 13,856 | ​ | ​ | 50,706 | ​ | ​ | 42,160
Acquisition-related cost of goods sold | ​ | ​ | 1,708 | ​ | ​ | 211 | ​ | ​ | 3,342 | ​ | ​ | 521
Acquisition-related other | ​ | ​ | 636 | ​ | ​ | 512 | ​ | ​ | 12,875 | ​ | ​ | 512
Pension settlement cost | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 10,674
Brazil employment taxes | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 4,202
Insurance settlement gain | ​ | ​ | (1,546) | ​ | ​ | (274) | ​ | ​ | (2,803) | ​ | ​ | (274)
Stock-based compensation expense | ​ | ​ | 179 | ​ | ​ | 135 | ​ | ​ | 538 | ​ | ​ | 296
Phibro Forward income growth initiatives - cost of goods sold (1) | ​ | ​ | 3,798 | ​ | ​ | — | ​ | ​ | 3,798 | ​ | ​ | —
Phibro Forward income growth initiatives - SG&A (1) | ​ | ​ | 3,980 | ​ | ​ | — | ​ | ​ | 6,026 | ​ | ​ | ​
Foreign currency (gains) losses, net | ​ |  | (5,528) | ​ |  | 2,427 | ​ |  | 6,609 | ​ |  | 16,593
Adjusted EBITDA – Total segments | ​ | $ | 72,221 | ​ | $ | 43,560 | ​ | $ | 184,423 | ​ | $ | 119,967
​
| (1) | Phibro Forward is a company-wide initiative focused on unlocking additional areas of revenue growth and cost savings. For the three and nine months ended March 31, 2025, this includes $5.3 million for non-cash asset write-offs, of which $3.8 million was recorded within cost of goods sold, and $1.5 million was recorded within selling, general, and administrative expenses, related to the closure of an immaterial business within the Animal Health segment.
Schedule of identifiable assets |
| (2) |
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, |  | June 30,
As of |  | 2025 |  | 2024
Identifiable assets |  | ​ |  |  | ​ |
Animal Health | ​ | $ | 1,041,878 | ​ | $ | 684,407
Mineral Nutrition | ​ |  | 78,922 | ​ |  | 67,088
Performance Products | ​ |  | 51,768 | ​ |  | 50,862
Total segments | ​ |  | 1,172,568 | ​ |  | 802,357
Corporate | ​ |  | 144,692 | ​ |  | 179,827
Total | ​ | $ | 1,317,260 | ​ | $ | 982,184

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration